The systemic immune response in Parkinson's disease: Focus on the peripheral immune component

J Lauritsen, M Romero-Ramos - Trends in neurosciences, 2023 - cell.com
During Parkinson's disease (PD), both the central nervous system (CNS) and peripheral
nervous system (PNS) are affected. In parallel, innate immune cells respond early to …

The immune system in Parkinson's disease: what we know so far

C Roodveldt, L Bernardino, O Oztop-Cakmak, M Dragic… - Brain, 2024 - academic.oup.com
Parkinson's disease is characterized neuropathologically by the degeneration of
dopaminergic neurons in the ventral midbrain, the accumulation of α-synuclein (α-syn) …

Single-cell transcriptome and TCR profiling reveal activated and expanded T cell populations in Parkinson's disease

P Wang, L Yao, M Luo, W Zhou, X **, Z Xu, S Yan… - Cell Discovery, 2021 - nature.com
Given the chronic inflammatory nature of Parkinson's disease (PD), T cell immunity may be
important for disease onset. Here, we performed single-cell transcriptome and TCR …

Global characterization of peripheral B cells in Parkinson's disease by single-cell RNA and BCR sequencing

P Wang, M Luo, W Zhou, X **, Z Xu, S Yan… - Frontiers in …, 2022 - frontiersin.org
Immune system plays important roles in the pathogenesis of Parkinson's disease (PD).
However, the role of B cells in this complex disease are still not fully understood. B cells …

Blood-based biomarker in Parkinson's disease: potential for future applications in clinical research and practice

L Tönges, C Buhmann, S Klebe, J Klucken… - Journal of Neural …, 2022 - Springer
The clinical presentation of Parkinson's disease (PD) is both complex and heterogeneous,
and its precise classification often requires an intensive work-up. The differential diagnosis …

[HTML][HTML] Natural killer cells in aging and age-related diseases

C Qi, Q Liu - Neurobiology of Disease, 2023 - Elsevier
Aging leads to escalated systemic inflammation. As the sentinel of immune system, natural
killer (NK) cells are early responders that sense cues and signals from target organs and …

T lymphocytes in Parkinson's disease

E Contaldi, L Magistrelli, C Comi - Journal of Parkinson's …, 2022 - content.iospress.com
T cells are key mediators of both humoral and cellular adaptive immune responses, and
their role in Parkinson's disease (PD) is being increasingly recognized. Several lines of …

How should we be using biomarkers in trials of disease modification in Parkinson's disease?

N Vijiaratnam, T Foltynie - Brain, 2023 - academic.oup.com
The recent validation of the α-synuclein seed amplification assay as a biomarker with high
sensitivity and specificity for the diagnosis of Parkinson's disease has formed the backbone …

[HTML][HTML] Calpain activation and progression of inflammatory cycles in Parkinson's disease

A Gao, HM McCoy, V Zaman, DC Shields… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Parkinson's disease (PD) is a progressive, neurodegenerative condition of the central
nervous system (CNS) affecting 6.3 million people worldwide with no curative treatments …

[HTML][HTML] Impact of sex on neuroimmune contributions to Parkinson's disease

M Bourque, M Morissette, D Soulet, T Di Paolo - Brain Research Bulletin, 2023 - Elsevier
Parkinson's disease (PD) is the second most common neurodegenerative disorder after
Alzheimer's disease. Inflammation has been observed in both the idiopathic and familial …